Evolution of hepatitis C virus non-structural 5A gene in the progression of liver disease to hepatocellular carcinoma

Liver International

Volumn 27, Issue 8, 2007, Pages 1126-1133

  De Mitri, Maria Stella ^a,d   Cassini, Romina ^a   Bagaglio, Sabrina ^b   Morsica, Giulia ^b   Andreone, Pietro ^a   Marino, Nicoletta ^c   Bernardi, Mauro ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c SANTA MARIA ANNUNZIATA HOSPITAL   (Italy)

^d UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Cirrhosis; Hepatitis C virus; Hepatocellular carcinoma; Non structural 5 A protein

Indexed keywords

NONSTRUCTURAL PROTEIN 5A; PROTEIN KINASE R;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DISEASE COURSE; FEMALE; FOLLOW UP; GENE SEQUENCE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LIVER CELL CARCINOMA; MALE; MOLECULAR CLONING; MOLECULAR EVOLUTION; PREVALENCE; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SEQUENCE ANALYSIS; VIRUS STRAIN; WILD TYPE;

AGED; AMINO ACID SEQUENCE; CARCINOMA, HEPATOCELLULAR; CELL TRANSFORMATION, NEOPLASTIC; DISEASE PROGRESSION; DNA MUTATIONAL ANALYSIS; DNA, VIRAL; EIF-2 KINASE; FEMALE; FOLLOW-UP STUDIES; HEPACIVIRUS; HEPATITIS C; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUTATION; RNA, VIRAL; SEQUENCE ANALYSIS, PROTEIN; VIRAL NONSTRUCTURAL PROTEINS;

EID: 34548639595     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2007.01537.x     Document Type: Article

References (41)

1. Seeff LB. Natural history of chronic hepatitis C. Hepatology 2002; 36: 35-46.
2. Llovet JM, Burrough A, Bruix J. Hepatocellular carcinoma. Lancet 2004; 362: 1907-17.
3. Angola M. Hepatocellular carcinoma: Role of hepatitis B and hepatitis C viruses proteins in hepatocarcinogenesis. J Viral Hepat 2004; 11: 383-93.
4. Pang R, Tse E, Poon RTP. Molecular pathways in hepatocellular carcinoma. Cancer Lett 2006; 1-13.
5. Tellinghuisen TL, Rice CM. Interaction between hepatitis C virus proteins and host cell factors. Curr Opin Microbiol 2002; 5: 419-27.
6. Enomoto N, Sakuma I, Asahina Y, et al. Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection. N Engl J Med 1996; 334: 77-81.
7. Enomoto N, Sakuma I, Asahina Y, et al. Comparison of full-length sequences of interferon-sensitive and resistant hepatitis C virus 1b: sensitivity to interferon is conferred by amino acid substitutions in the NS5A region. J Clin Invest 1995; 96: 224-30.
8. Chung KM, Song O-K, Jang SK. Hepatitis C virus nonstructural protein 5A contains potential transcriptional activator domains. Mol Cells 1997; 7: 661-7.
9. Kato N, Lan KH, Ono-Nita SK, et al. Hepatitis C virus nonstructural region 5A protein is a potent transcriptional activator. J Virol 1997; 71: 8856-9.
10. Ghosh AK, Steele R, Meyer K, et al. Hepatitis C virus NS5A protein modulates cell cycle regulatory genes and promotes cell growth. J Gen Virol 1999; 80: 1179-83.
11. Gale JM, Korth MJ, Tang NM, et al. Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein. Virology 1997; 230: 217-27.
12. Gale M Jr., Blakely CM, Kwieciszewski B, et al. Control of PKR protein kinase by hepatitis C virus nonstructural 5A protein: Molecular mechanisms of kinase regulation. Mol Cell Biol 1998; 18: 5208-18.
13. Barber GN, Jagus R, Meurs EF, et al. Molecular mechanisms responsible for malignant transformation by regulatory and catalytic domain variants of the interferon-induced enzyme RNA-dependent protein kinase. J Biol Chem 1995; 270: 17423-8.
14. Arima N, Kao CY, Licht T, et al. Modulation of cell growth by the hepatitis C virus non-structural protein NS5A. J Biol Chem 2001; 276: 12675-84.
15. Meurs EF, Galabru J, Barber GN, et al. Tumor suppressor function of the interferon-induced double stranded RNA-activated protein kinase. Proc Natl Acad Sci USA 1993; 90: 232-6.
16. Gale M Jr., Kwieciszewski B, Dossett M, et al. Antiapoptotic and oncogenic potential of hepatitis C virus are linked to interferon resistence by viral repression of the PKR protein kinase. J Virol 1999; 73: 6506-16.
17. Trevisani F, D'Intino PE, Morselli-Labate AM, et al. Serum alpha-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: Influence of HBsAg and anti-HCV status. J Hepatol 2001; 34: 570-5.
18. Chomczynsky P, Sacchi N. Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chlorophorm extraction. Anal Biochem 1987; 162: 156-9.
19. De Mitri MS, Morsica G, Cassini R, et al. Prevalence of wild-type in NS5A-PKR protein kinase binding domain in HCV-related hepatocellular carcinoma. J Hepatol 2002; 36: 116-22.
20. Thompson JD, Gibson TJ, Plewniak F, et al. The CLUSTAL_X windows interface: Flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucl Acid Res 1997; 25: 4876-82.
21. Kato N, Hijikata M, Ootsuyama Y, et al. Molecular cloning of the human hepatitis C virus genoma from Japanese patients with non-A, non-B hepatitis. Proc Natl Acad Sci USA 1990; 87: 9524-8.
22. Martell M, Esteban J, Quer J, et al. Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: Quasispecie nature of HCV genome distribution. J Virol 1992; 66: 3225-9.
23. Bowen DG, Wlaker CM. The origin of quasispecies: Cause or consequence of chronic hepatitis C viral infection? J Hepatol 2005; 42: 408-17.
24. Bukh J, Miller RH, Purcell RH. Genetic heterogeneity of hepatitis C virus: Quasispecies and genotype. Semin Liver Dis 2005; 15: 41-63.
25. De Mitri MS, Mele L, Chen CH, et al. Comparison of serum and liver hepatitis C virus quasispecies in HCV-related hepatocellular carcinoma. J Hepatol 1998; 29: 887-92.
26. Bagaglio S, De Mitri MS, Lodrini S, et al. Mutations in the E2-PePHD region of hepatitis C virus type 1b in patients with hepatocellular carcinoma. J Virol 2005; 12: 243-50.
27. Gimenez-Barcons M, Wang C, Chen M, et al. The oncogenic potential of hepatitis C virus NS5A sequence variants is associated with PKR regulation. J Interferon Cytokine Res 2005; 25: 152-64.
28. Gao L, Aizaki H, He JW, Lai MM. Interactions between viral non-structural proteins and host protein hVAP-33 mediate the formation of hepatitis C virus RNA replication complex on lipid raft. J Viral Hepat 2004; 78: 3480-8.
29. Tan S-L, Nakao H, He Y, et al. NS5A, a nonstructural protein of hepatitis C virus, binds growth factor receptor-bound protein 2 adaptor protein in a Src homology 3 domain/ligand-dependent manner and perturbs mitogenic signaling. Proc Natl Acad Sci USA 1999; 96: 5533-8.
30. Lan KH, Sheu ML, Hwang SJ, et al. HCV NS5A interact with p53 and inhibit p53-mediated apoptosis. Oncogene 2002; 21: 4801-11.
31. Majunder M, Ghosh AK, Steele R, et al. Hepatitis C virus NS5A physically associates with p53 and regulates p21/waf1 gene expression in a p53-dependent manner. J Virol 2001; 75: 1401-7.
32. Macdonald A, Harris M. Hepatitis C virus NS5A: Tales of a promiscuous protein. J Gen Virol 2004; 85: 2485-502.
33. Reyes GR. The nonstructural NS5A protein of hepatitis C virus: An expanding multifunctional role in enhancing hepatitis C virus pathogenesis. J Biomed Sci 2002; 9: 187-97.
34. Fan W, Ziiu W, Wei L, et al. Nonstructural 5A gene variability of hepatitis C virus (HCV) during a 10-year follow up. J Gastroenterol 2005; 40: 43-51.
35. Maekawa S, Enomoto N, Kurosaki M, et al. Genetic changes in interferon sensitivity determining region of hepatitis C virus during the natural course of chronic hepatitis C. J Med Virol 2000; 61: 303-10.
36. Franco S, Gimenez-Barcons M, Puig-Basagoiti F, et al. Characterization and evolution of NS5A quasispecies of hepatitis C virus genotype 1b in patients with different stages of liver disease. J Med Virol 2003; 71: 195-204.
37. Lohmann V, Korner F, Doberzewska A, Bartenschlager R. Mutations in hepatitis C virus RNAs conferring cell culture adaptation. J Virol 2001; 75: 1437-49.
38. Baek KH, Park HY, Kang CM, et al. Overexpression of hepatitis C virus NS5A protein induces chromosome instability via mitotic cell cycle dysregulation. J Mol Biol 2006; 359: 22-34.
39. Blight KJ, McKeating JA, Rice CM. Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication. J Virol 2002; 76: 13001-14.
40. Lohmann V, Hoffmann S, Herian U, et al. Viral and cellular determinants of hepatitis C virus RNA replication in cell culture. J Virol 2003; 77: 3007-19.
41. Sarrazin C, Mihm U, Herrmann E, et al. Clinical significance of in vitro replication-enhancing mutations of the hepatitis C virus (HCV) replicon in patients with chronic HCV infection. J Infec Dis 2005; 192: 1710-9.